569 related articles for article (PubMed ID: 29555626)
1. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
2. Two Novel Bacteriophages Improve Survival in
Jeon J; Yong D
Appl Environ Microbiol; 2019 May; 85(9):. PubMed ID: 30824445
[TBL] [Abstract][Full Text] [Related]
3. Activity of Bacteriophages in Removing Biofilms of
Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ
Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773
[No Abstract] [Full Text] [Related]
4. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.
Olszak T; Zarnowiec P; Kaca W; Danis-Wlodarczyk K; Augustyniak D; Drevinek P; de Soyza A; McClean S; Drulis-Kawa Z
Appl Microbiol Biotechnol; 2015 Jul; 99(14):6021-33. PubMed ID: 25758956
[TBL] [Abstract][Full Text] [Related]
6. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients.
Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK
AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776
[TBL] [Abstract][Full Text] [Related]
7. Effects of sequential and simultaneous applications of bacteriophages on populations of Pseudomonas aeruginosa in vitro and in wax moth larvae.
Hall AR; De Vos D; Friman VP; Pirnay JP; Buckling A
Appl Environ Microbiol; 2012 Aug; 78(16):5646-52. PubMed ID: 22660719
[TBL] [Abstract][Full Text] [Related]
8. Efficacy assessment of PEV2 phage on Galleria mellonella larvae infected with a Pseudomonas aeruginosa dog otitis isolate.
Antoine C; Laforêt F; Blasdel B; Glonti T; Kutter E; Pirnay JP; Mainil J; Delcenserie V; Thiry D
Res Vet Sci; 2021 May; 136():598-601. PubMed ID: 33895568
[TBL] [Abstract][Full Text] [Related]
9. Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis.
Furusawa T; Iwano H; Hiyashimizu Y; Matsubara K; Higuchi H; Nagahata H; Niwa H; Katayama Y; Kinoshita Y; Hagiwara K; Iwasaki T; Tanji Y; Yokota H; Tamura Y
Appl Environ Microbiol; 2016 Sep; 82(17):5332-9. PubMed ID: 27342558
[TBL] [Abstract][Full Text] [Related]
10. A proposed integrated approach for the preclinical evaluation of phage therapy in Pseudomonas infections.
Danis-Wlodarczyk K; Vandenheuvel D; Jang HB; Briers Y; Olszak T; Arabski M; Wasik S; Drabik M; Higgins G; Tyrrell J; Harvey BJ; Noben JP; Lavigne R; Drulis-Kawa Z
Sci Rep; 2016 Jun; 6():28115. PubMed ID: 27301427
[TBL] [Abstract][Full Text] [Related]
11. Lytic bacteriophages induce the secretion of antiviral and proinflammatory cytokines from human respiratory epithelial cells.
Zamora PF; Reidy TG; Armbruster CR; Sun M; Van Tyne D; Turner PE; Koff JL; Bomberger JM
PLoS Biol; 2024 Apr; 22(4):e3002566. PubMed ID: 38652717
[TBL] [Abstract][Full Text] [Related]
12. A novel bacteriophage cocktail reduces and disperses Pseudomonas aeruginosa biofilms under static and flow conditions.
Alves DR; Perez-Esteban P; Kot W; Bean JE; Arnot T; Hansen LH; Enright MC; Jenkins AT
Microb Biotechnol; 2016 Jan; 9(1):61-74. PubMed ID: 26347362
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial.
Jault P; Leclerc T; Jennes S; Pirnay JP; Que YA; Resch G; Rousseau AF; Ravat F; Carsin H; Le Floch R; Schaal JV; Soler C; Fevre C; Arnaud I; Bretaudeau L; Gabard J
Lancet Infect Dis; 2019 Jan; 19(1):35-45. PubMed ID: 30292481
[TBL] [Abstract][Full Text] [Related]
14. Bacteriophage cocktail shows no toxicity and improves the survival of
Kelly L; Jameson E
J Virol; 2024 Jun; 98(6):e0027224. PubMed ID: 38771043
[No Abstract] [Full Text] [Related]
15. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
Rossitto M; Fiscarelli EV; Rosati P
Front Microbiol; 2018; 9():775. PubMed ID: 29780361
[TBL] [Abstract][Full Text] [Related]
16. Bacteriophage Delivery by Nebulization and Efficacy Against Phenotypically Diverse Pseudomonas aeruginosa from Cystic Fibrosis Patients.
Sahota JS; Smith CM; Radhakrishnan P; Winstanley C; Goderdzishvili M; Chanishvili N; Kadioglu A; O'Callaghan C; Clokie MR
J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):353-60. PubMed ID: 25714328
[TBL] [Abstract][Full Text] [Related]
17. Identification and impact on
Forti F; Bertoli C; Cafora M; Gilardi S; Pistocchi A; Briani F
Microbiol Spectr; 2023 Dec; 11(6):e0147723. PubMed ID: 37966242
[TBL] [Abstract][Full Text] [Related]
18. Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model.
Cafora M; Deflorian G; Forti F; Ferrari L; Binelli G; Briani F; Ghisotti D; Pistocchi A
Sci Rep; 2019 Feb; 9(1):1527. PubMed ID: 30728389
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of Pseudomonas aeruginosa veterinary isolates to Pbunavirus PB1-like phages.
Fujiki J; Furusawa T; Munby M; Kawaguchi C; Matsuda Y; Shiokura Y; Nakamura K; Nakamura T; Sasaki M; Usui M; Iwasaki T; Gondaira S; Higuchi H; Sawa H; Tamura Y; Iwano H
Microbiol Immunol; 2020 Nov; 64(11):778-782. PubMed ID: 32918505
[TBL] [Abstract][Full Text] [Related]
20. Broad host range phages target global
Thanki AM; Osei EK; Whenham N; Salter MG; Bedford MR; Masey O'Neill HV; Clokie MRJ
Microbiol Spectr; 2024 May; 12(5):e0378423. PubMed ID: 38511948
[No Abstract] [Full Text] [Related]
[Next] [New Search]
